Alendronate Plus D3 70 mg/140 ug APOTEX alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

colecalciferol, Quantity: 140 microgram; alendronate sodium, Quantity: 91.37 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

alendronate sodium,colecalciferol

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; butylated hydroxytoluene

Mode d'administration:

Oral

Unités en paquet:

4

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Alendronate Plus D 70 mg/70 ?g and Alendronate Plus D 70 mg/140 ?g tablets are indicated for the treatment of:,Osteoporosis in select patients where vitamin D supplementation is recommended.,Prior to treatment, osteroporosis must be confirmed by:,The finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,The presence of osteoporotic fracture

Descriptif du produit:

Visual Identification: White to off-white, rectangular, biconvex tablet. Engraved APO on one side, ALE-D56 on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-12-17